Birdwatch Note Rating
2024-05-30 17:31:15 UTC - NOT_HELPFUL
Rated by Participant: D19EA15185DBC24DBC4245B28D269254DD47DDEDD8C9D6C949B03905F5A94B59
Participant Details
Original Note:
While the court admission by AstraZeneca is a notable development, it is not the first time the potential for rare blood clots associated with the vaccine has been recognized. Health authorities had identified and communicated this risk as early as 2021. https://www.factcheck.org/2024/05/scicheck-misleading-claims-on-well-known-rare-risk-of-astrazeneca-covid-19-vaccine/ https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-benefits-and-risks-context https://www.ema.europa.eu/en/news/astrazeneca-covid-19-vaccine-review-very-rare-cases-unusual-blood-clots-continues https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets https://www.telegraph.co.uk/news/2024/04/28/astrazeneca-admits-covid-vaccine-causes-rare-side-effect/
All Note Details